Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility
Phosphodiesterase (PDE) inhibitors can improve sperm motility in patients with asthenozoospermia. However, the most commonly reported nonselective PDE inhibitor pentoxifylline and PDE5 inhibitor sildenafil have the disadvantages of requiring a high concentration and destroying sperm integrity. We ex...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Asian Journal of Andrology |
| Subjects: | |
| Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2023;volume=25;issue=5;spage=608;epage=615;aulast=Yang |
| _version_ | 1797649536299040768 |
|---|---|
| author | Yi-Ting Yang Bin Yan Yu-Hua Li Li-Na Guo Wei-Wei Wang Li-Jie Liu He-Guo Yu Hua Diao |
| author_facet | Yi-Ting Yang Bin Yan Yu-Hua Li Li-Na Guo Wei-Wei Wang Li-Jie Liu He-Guo Yu Hua Diao |
| author_sort | Yi-Ting Yang |
| collection | DOAJ |
| description | Phosphodiesterase (PDE) inhibitors can improve sperm motility in patients with asthenozoospermia. However, the most commonly reported nonselective PDE inhibitor pentoxifylline and PDE5 inhibitor sildenafil have the disadvantages of requiring a high concentration and destroying sperm integrity. We examined the PDE10A inhibitor PF-2545920 to compare its ability to promote sperm motility with that of pentoxifylline and sildenafil. After seminal plasma was discarded, several semen samples were subjected to four treatments (control, PF-2545920, pentoxifylline, and sildenafil) to evaluate their ability to affect motility, viability, and spontaneous acrosome reactions. Intracellular calcium and adenosine triphosphate (ATP), mitochondrial membrane potential, and penetration through viscous medium were assessed by flow cytometry, luciferase, and hyaluronic acid after treatment with PF-2545920. Statistical analyses were performed using the analysis of variance statistical test. PF-2545920 elevated the percentage of motile spermatozoa compared to the control, pentoxifylline, and sildenafil groups at 10 μmol l−1 (P < 0.01). It is less toxic to GC-2spd mouse spermatocytes cells and spermatozoa and causes fewer spontaneous acrosomal reactions (P < 0.05). PF-2545920 also increased mitochondrial membrane potential (P < 0.001) and altered intracellular calcium (P < 0.05) in a dose-dependent manner, including increasing sperm hyaluronic acid penetrating ability (P < 0.05). Therefore, PF-2545920 might be an excellent choice for stimulating the sperm motility. |
| first_indexed | 2024-03-11T15:47:33Z |
| format | Article |
| id | doaj.art-e471b713a6c442b480c035f8fddda318 |
| institution | Directory Open Access Journal |
| issn | 1008-682X 1745-7262 |
| language | English |
| last_indexed | 2024-03-11T15:47:33Z |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Asian Journal of Andrology |
| spelling | doaj.art-e471b713a6c442b480c035f8fddda3182023-10-26T05:48:56ZengWolters Kluwer Medknow PublicationsAsian Journal of Andrology1008-682X1745-72622023-01-0125560861510.4103/aja2022117Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motilityYi-Ting YangBin YanYu-Hua LiLi-Na GuoWei-Wei WangLi-Jie LiuHe-Guo YuHua DiaoPhosphodiesterase (PDE) inhibitors can improve sperm motility in patients with asthenozoospermia. However, the most commonly reported nonselective PDE inhibitor pentoxifylline and PDE5 inhibitor sildenafil have the disadvantages of requiring a high concentration and destroying sperm integrity. We examined the PDE10A inhibitor PF-2545920 to compare its ability to promote sperm motility with that of pentoxifylline and sildenafil. After seminal plasma was discarded, several semen samples were subjected to four treatments (control, PF-2545920, pentoxifylline, and sildenafil) to evaluate their ability to affect motility, viability, and spontaneous acrosome reactions. Intracellular calcium and adenosine triphosphate (ATP), mitochondrial membrane potential, and penetration through viscous medium were assessed by flow cytometry, luciferase, and hyaluronic acid after treatment with PF-2545920. Statistical analyses were performed using the analysis of variance statistical test. PF-2545920 elevated the percentage of motile spermatozoa compared to the control, pentoxifylline, and sildenafil groups at 10 μmol l−1 (P < 0.01). It is less toxic to GC-2spd mouse spermatocytes cells and spermatozoa and causes fewer spontaneous acrosomal reactions (P < 0.05). PF-2545920 also increased mitochondrial membrane potential (P < 0.001) and altered intracellular calcium (P < 0.05) in a dose-dependent manner, including increasing sperm hyaluronic acid penetrating ability (P < 0.05). Therefore, PF-2545920 might be an excellent choice for stimulating the sperm motility.http://www.ajandrology.com/article.asp?issn=1008-682X;year=2023;volume=25;issue=5;spage=608;epage=615;aulast=Yangpentoxifylline; phosphodiesterase 10a; sildenafil; sperm motility; spontaneous acrosome reaction |
| spellingShingle | Yi-Ting Yang Bin Yan Yu-Hua Li Li-Na Guo Wei-Wei Wang Li-Jie Liu He-Guo Yu Hua Diao Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility Asian Journal of Andrology pentoxifylline; phosphodiesterase 10a; sildenafil; sperm motility; spontaneous acrosome reaction |
| title | Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility |
| title_full | Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility |
| title_fullStr | Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility |
| title_full_unstemmed | Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility |
| title_short | Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility |
| title_sort | phosphodiesterase 10a inhibitor pf 2545920 as a prospective agent for the clinical promotion of sperm motility |
| topic | pentoxifylline; phosphodiesterase 10a; sildenafil; sperm motility; spontaneous acrosome reaction |
| url | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2023;volume=25;issue=5;spage=608;epage=615;aulast=Yang |
| work_keys_str_mv | AT yitingyang phosphodiesterase10ainhibitorpf2545920asaprospectiveagentfortheclinicalpromotionofspermmotility AT binyan phosphodiesterase10ainhibitorpf2545920asaprospectiveagentfortheclinicalpromotionofspermmotility AT yuhuali phosphodiesterase10ainhibitorpf2545920asaprospectiveagentfortheclinicalpromotionofspermmotility AT linaguo phosphodiesterase10ainhibitorpf2545920asaprospectiveagentfortheclinicalpromotionofspermmotility AT weiweiwang phosphodiesterase10ainhibitorpf2545920asaprospectiveagentfortheclinicalpromotionofspermmotility AT lijieliu phosphodiesterase10ainhibitorpf2545920asaprospectiveagentfortheclinicalpromotionofspermmotility AT heguoyu phosphodiesterase10ainhibitorpf2545920asaprospectiveagentfortheclinicalpromotionofspermmotility AT huadiao phosphodiesterase10ainhibitorpf2545920asaprospectiveagentfortheclinicalpromotionofspermmotility |